1. Home
  2. ECOR vs CREX Comparison

ECOR vs CREX Comparison

Compare ECOR & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • CREX
  • Stock Information
  • Founded
  • ECOR 2005
  • CREX N/A
  • Country
  • ECOR United States
  • CREX United States
  • Employees
  • ECOR N/A
  • CREX N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CREX EDP Services
  • Sector
  • ECOR Health Care
  • CREX Technology
  • Exchange
  • ECOR Nasdaq
  • CREX Nasdaq
  • Market Cap
  • ECOR 37.1M
  • CREX 35.2M
  • IPO Year
  • ECOR 2018
  • CREX N/A
  • Fundamental
  • Price
  • ECOR $4.83
  • CREX $2.31
  • Analyst Decision
  • ECOR Strong Buy
  • CREX Strong Buy
  • Analyst Count
  • ECOR 2
  • CREX 1
  • Target Price
  • ECOR $25.50
  • CREX $6.00
  • AVG Volume (30 Days)
  • ECOR 62.4K
  • CREX 46.8K
  • Earning Date
  • ECOR 11-12-2025
  • CREX 11-12-2025
  • Dividend Yield
  • ECOR N/A
  • CREX N/A
  • EPS Growth
  • ECOR N/A
  • CREX N/A
  • EPS
  • ECOR N/A
  • CREX N/A
  • Revenue
  • ECOR $27,700,000.00
  • CREX $48,218,000.00
  • Revenue This Year
  • ECOR $24.48
  • CREX $4.96
  • Revenue Next Year
  • ECOR $44.35
  • CREX $21.73
  • P/E Ratio
  • ECOR N/A
  • CREX N/A
  • Revenue Growth
  • ECOR 30.16
  • CREX N/A
  • 52 Week Low
  • ECOR $4.16
  • CREX $1.28
  • 52 Week High
  • ECOR $19.49
  • CREX $4.85
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 41.17
  • CREX 42.57
  • Support Level
  • ECOR $4.70
  • CREX $2.21
  • Resistance Level
  • ECOR $5.25
  • CREX $2.38
  • Average True Range (ATR)
  • ECOR 0.26
  • CREX 0.15
  • MACD
  • ECOR 0.01
  • CREX 0.00
  • Stochastic Oscillator
  • ECOR 13.00
  • CREX 19.61

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: